Dawn L. Hershman
Breast oncologist who co-leads SWOG and studies adherence, toxicity, and how care is actually delivered.
Dawn Hershman is a medical oncologist and health outcomes researcher. Co-chairs SWOG with Primo Lara. Led SWOG's cancer care delivery research and trials on chemotherapy-induced neuropathy and endocrine therapy adherence.
Pages like this
not linked directly; found by shared links- PersonMariana Chavez-MacGregor
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- PersonPriyanka Sharma
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- PersonKathy S. Albain
Shares SWOG Cancer Research Network, HR-positive / HER2-negative breast cancer.
- TrialSCARLET (SWOG S2212)
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- InstitutionThe University of Kansas Cancer Center
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- IdeaA permanent neutral non-profit sponsor for multi-company platform trials
Shares SWOG Cancer Research Network, Triple-negative breast cancer (TNBC).
- InstitutionWinship Cancer Institute of Emory University
Shares SWOG Cancer Research Network, HR-positive / HER2-negative breast cancer.